GRPEL2
gene geneOn this page
Also known as DKFZp451C205Mt-GrpE#2FLJ23713
Summary
GRPEL2 (GrpE like 2, mitochondrial, HGNC:21060) is a protein-coding gene on chromosome 5q32, encoding GrpE protein homolog 2, mitochondrial (Q8TAA5). Essential component of the PAM complex, a complex required for the translocation of transit peptide-containing proteins from the inner membrane into the mitochondrial matrix in an ATP-dependent manner.
Predicted to enable adenyl-nucleotide exchange factor activity and unfolded protein binding activity. Predicted to be involved in protein import into mitochondrial matrix. Located in mitochondrion.
Source: NCBI Gene 134266 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 37 total
- MANE Select transcript:
NM_152407
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21060 |
| Approved symbol | GRPEL2 |
| Name | GrpE like 2, mitochondrial |
| Location | 5q32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp451C205, Mt-GrpE#2, FLJ23713 |
| Ensembl gene | ENSG00000164284 |
| Ensembl biotype | protein_coding |
| OMIM | 618545 |
| Entrez | 134266 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000329271, ENST00000416916, ENST00000507562, ENST00000513661, ENST00000913747
RefSeq mRNA: 1 — MANE Select: NM_152407
NM_152407
CCDS: CCDS4295
Canonical transcript exons
ENST00000329271 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003502866 | 149348272 | 149348425 |
| ENSE00003576362 | 149349654 | 149349735 |
| ENSE00003662005 | 149350918 | 149354583 |
| ENSE00003842982 | 149345499 | 149345616 |
Expression profiles
Bgee: expression breadth ubiquitous, 251 present calls, max score 98.26.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 24.0356 / max 195.8147, expressed in 1802 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 59358 | 23.8140 | 1801 |
| 59357 | 0.2216 | 88 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 98.26 | gold quality |
| buccal mucosa cell | CL:0002336 | 94.89 | gold quality |
| oocyte | CL:0000023 | 93.64 | gold quality |
| secondary oocyte | CL:0000655 | 92.14 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 91.29 | gold quality |
| oviduct epithelium | UBERON:0004804 | 90.22 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 89.00 | gold quality |
| esophagus mucosa | UBERON:0002469 | 88.63 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.42 | gold quality |
| oral cavity | UBERON:0000167 | 87.76 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 86.91 | silver quality |
| medial globus pallidus | UBERON:0002477 | 86.16 | gold quality |
| gingiva | UBERON:0001828 | 85.47 | gold quality |
| tibialis anterior | UBERON:0001385 | 85.46 | silver quality |
| kidney epithelium | UBERON:0004819 | 85.39 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.26 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 84.80 | gold quality |
| deltoid | UBERON:0001476 | 84.47 | silver quality |
| epithelium of mammary gland | UBERON:0003244 | 84.45 | gold quality |
| mammary duct | UBERON:0001765 | 84.43 | gold quality |
| pancreatic ductal cell | CL:0002079 | 84.36 | silver quality |
| upper arm skin | UBERON:0004263 | 84.35 | silver quality |
| cortical plate | UBERON:0005343 | 84.28 | gold quality |
| cerebellar vermis | UBERON:0004720 | 84.12 | gold quality |
| ventricular zone | UBERON:0003053 | 83.93 | gold quality |
| endothelial cell | CL:0000115 | 83.73 | silver quality |
| globus pallidus | UBERON:0001875 | 83.70 | gold quality |
| ganglionic eminence | UBERON:0004023 | 83.52 | gold quality |
| lower lobe of lung | UBERON:0008949 | 83.17 | gold quality |
| mammalian vulva | UBERON:0000997 | 83.09 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.02 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
173 targeting GRPEL2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-196A-5P | 100.00 | 68.16 | 684 |
| HSA-MIR-196B-5P | 100.00 | 68.16 | 681 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-520G-5P | 99.99 | 66.76 | 658 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
Literature-anchored findings (GeneRIF, showing 4)
- Data suggest that two putative NEF (nucleotide exchange factors) orthologs, GRPEL1 and GRPEL2, modulate function of mitochondrial HSP70 (mtHSP70); both GRPEL1 and GRPEL2 associate with mtHSP70 as hetero-oligomeric subcomplex and regulate mtHSP70 transport. (GRPEL = mitochondrial GrpE-like protein; HSP70 = heat-shock protein 70) (PMID:28848044)
- The dimerization of GRPEL2 may activate the folding machinery responsible for protein import into mitochondrial matrix or enhance the chaperone activity of mitochondrial HSP70, thus protecting mitochondrial proteostasis in oxidative stress. (PMID:30098457)
- GRPEL2 Knockdown Exerts Redox Regulation in Glioblastoma. (PMID:34884508)
- Preferential binding of ADP-bound mitochondrial HSP70 to the nucleotide exchange factor GRPEL1 over GRPEL2. (PMID:39445986)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | grpel2 | ENSDARG00000069421 |
| mus_musculus | Grpel2 | ENSMUSG00000024580 |
| rattus_norvegicus | Grpel2 | ENSRNOG00000064275 |
| drosophila_melanogaster | Roe1 | FBGN0014877 |
| caenorhabditis_elegans | WBGENE00007927 |
Paralogs (1): GRPEL1 (ENSG00000109519)
Protein
Protein identifiers
GrpE protein homolog 2, mitochondrial — Q8TAA5 (reviewed: Q8TAA5)
Alternative names: Mt-GrpE#2
All UniProt accessions (2): Q8TAA5, D6RGI6
UniProt curated annotations — full annotation on UniProt →
Function. Essential component of the PAM complex, a complex required for the translocation of transit peptide-containing proteins from the inner membrane into the mitochondrial matrix in an ATP-dependent manner. Seems to control the nucleotide-dependent binding of mitochondrial HSP70 to substrate proteins. Stimulates ATPase activity of mt-HSP70. May also serve to modulate the interconversion of oligomeric (inactive) and monomeric (active) forms of mt-HSP70.
Subunit / interactions. Probable component of the PAM complex at least composed of a mitochondrial HSP70 protein, GRPEL1 or GRPEL2, TIMM44, TIMM16/PAM16 and TIMM14/DNAJC19.
Subcellular location. Mitochondrion matrix.
Similarity. Belongs to the GrpE family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8TAA5-1 | 1 | yes |
| Q8TAA5-2 | 2 |
RefSeq proteins (1): NP_689620* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000740 | GrpE | Family |
| IPR009012 | GrpE_head | Homologous_superfamily |
| IPR013805 | GrpE_CC | Homologous_superfamily |
Pfam: PF01025
UniProt features (5 total): splice variant 2, transit peptide 1, chain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TAA5-F1 | 78.71 | 0.54 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 142
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-1268020 | Mitochondrial protein import |
MSigDB gene sets: 173 (showing top):
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, AAGCCAT_MIR135A_MIR135B, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_PROTEIN_MATURATION, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_PROTEIN_FOLDING, CHO_NR4A1_TARGETS, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, FISCHER_DREAM_TARGETS, SENESE_HDAC1_TARGETS_UP, GOBP_PROTEIN_TRANSMEMBRANE_TRANSPORT, WONG_MITOCHONDRIA_GENE_MODULE, GOBP_PROTEIN_LOCALIZATION_TO_MITOCHONDRION, ACEVEDO_LIVER_CANCER_UP
GO Biological Process (3): protein folding (GO:0006457), intracellular protein transport (GO:0006886), protein import into mitochondrial matrix (GO:0030150)
GO Molecular Function (5): adenyl-nucleotide exchange factor activity (GO:0000774), protein homodimerization activity (GO:0042803), obsolete unfolded protein binding (GO:0051082), protein-folding chaperone binding (GO:0051087), protein binding (GO:0005515)
GO Cellular Component (5): PAM complex, Tim23 associated import motor (GO:0001405), mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), TIM23 mitochondrial import inner membrane translocase complex (GO:0005744), mitochondrial matrix (GO:0005759)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Protein localization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| inner mitochondrial membrane protein complex | 2 |
| cellular process | 1 |
| protein maturation | 1 |
| intracellular protein localization | 1 |
| protein transport | 1 |
| intracellular transport | 1 |
| protein transmembrane import into intracellular organelle | 1 |
| protein localization to mitochondrion | 1 |
| import into the mitochondrion | 1 |
| mitochondrial protein import pathway | 1 |
| ATP binding | 1 |
| ADP binding | 1 |
| ATPase regulator activity | 1 |
| identical protein binding | 1 |
| protein dimerization activity | 1 |
| protein binding | 1 |
| binding | 1 |
| TIM23 mitochondrial import inner membrane translocase complex | 1 |
| mitochondrial matrix | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| mitochondrion | 1 |
| intracellular organelle lumen | 1 |
Protein interactions and networks
STRING
2468 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GRPEL2 | DNAJA3 | Q96EY1 | 707 |
| GRPEL2 | HSPA9 | P30036 | 605 |
| GRPEL2 | AFAP1L1 | Q8TED9 | 575 |
| GRPEL2 | HSPA12A | O43301 | 572 |
| GRPEL2 | HSPE1 | P61604 | 551 |
| GRPEL2 | CLPX | O76031 | 523 |
| GRPEL2 | CEBPG | P53567 | 514 |
| GRPEL2 | CHAC1 | Q9BUX1 | 505 |
| GRPEL2 | PAM16 | Q9Y3D7 | 503 |
| GRPEL2 | HSPA8 | P11142 | 490 |
| GRPEL2 | DNAJC19 | Q96DA6 | 462 |
| GRPEL2 | DNLZ | Q5SXM8 | 461 |
| GRPEL2 | RCBTB2 | O95199 | 459 |
| GRPEL2 | CTNNAL1 | Q9UBT7 | 453 |
| GRPEL2 | TRIB3 | Q96RU7 | 453 |
IntAct
17 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GRPEL2 | DBT | psi-mi:“MI:0914”(association) | 0.710 |
| GRPEL2 | DBT | psi-mi:“MI:0915”(physical association) | 0.710 |
| GRPEL1 | HSPA9 | psi-mi:“MI:0914”(association) | 0.670 |
| HSCB | RBP5 | psi-mi:“MI:0914”(association) | 0.350 |
| OXLD1 | NUDT19 | psi-mi:“MI:0914”(association) | 0.350 |
| MRM1 | KIAA0391 | psi-mi:“MI:0914”(association) | 0.350 |
| GRPEL1 | TPPP | psi-mi:“MI:0914”(association) | 0.350 |
| MRM1 | PRORP | psi-mi:“MI:0914”(association) | 0.350 |
| OXLD1 | PRORP | psi-mi:“MI:0914”(association) | 0.350 |
| SPX | ERI3 | psi-mi:“MI:0914”(association) | 0.350 |
| DDX54 | SYNCRIP | psi-mi:“MI:0914”(association) | 0.350 |
| GNLY | PRKCI | psi-mi:“MI:0914”(association) | 0.350 |
| FECH | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| GRPEL2 | FAM83G | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (43): GRPEL2 (Affinity Capture-MS), MUT (Affinity Capture-MS), DBT (Affinity Capture-MS), NDUFAF5 (Affinity Capture-MS), YES1 (Affinity Capture-MS), C7orf55 (Affinity Capture-MS), LYRM7 (Affinity Capture-MS), GRPEL2 (Affinity Capture-MS), GRPEL2 (Affinity Capture-MS), GRPEL2 (Affinity Capture-MS), GRPEL2 (Affinity Capture-MS), GRPEL2 (Affinity Capture-MS), DBT (Affinity Capture-MS), C7orf55 (Affinity Capture-MS), MUT (Affinity Capture-MS)
ESM2 similar proteins: A1A4J8, A5PK26, O35231, O88396, P19686, P19687, P36407, P48760, P97576, Q07617, Q0P5N5, Q15027, Q1JQC5, Q1L5Z9, Q32KL4, Q3SZC1, Q3UY23, Q4G069, Q4R380, Q502I6, Q5R435, Q5R8E4, Q5RA81, Q5U2X2, Q60443, Q6DKK2, Q6PBQ2, Q7SXA9, Q80VP5, Q80Y81, Q80ZX8, Q8BMS4, Q8BUI3, Q8C9A2, Q8CGS5, Q8CI66, Q8IWL3, Q8K2H4, Q8K3A0, Q8NFF5
Diamond homologs: A0K4S6, A0Q7F1, A1TLI0, A1UUC9, A1WX32, A3MNA1, A4IX27, A4JBR9, A4SQ26, A5IDK9, A5VNA6, A6U5E2, A6WVA7, A7HZ43, A7NCM8, A9AGC0, A9IGC0, A9ILE9, A9M7B6, B0CJ30, B0T367, B0TYF1, B0UT70, B1JW17, B2IDD9, B2SXC5, B3PZA4, B3Q970, B3R450, B4EDZ4, B5ZMX0, B6JCI1, B8ET77, B8F790, B8GXP4, B8IJD7, B9JZG5, C5BQ34, O08384, O32481
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| GRPEL2 | “form complex” | “TIM23 complex” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
37 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
419 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:149345613:GCAA:G | donor_gain | 1.0000 |
| 5:149345617:G:GG | donor_gain | 1.0000 |
| 5:149348264:T:A | acceptor_gain | 1.0000 |
| 5:149348267:TTTAG:T | acceptor_loss | 1.0000 |
| 5:149348269:TA:T | acceptor_loss | 1.0000 |
| 5:149348270:A:AG | acceptor_gain | 1.0000 |
| 5:149348270:AG:A | acceptor_gain | 1.0000 |
| 5:149348270:AGG:A | acceptor_gain | 1.0000 |
| 5:149348270:AGGG:A | acceptor_gain | 1.0000 |
| 5:149348271:G:GA | acceptor_gain | 1.0000 |
| 5:149348271:GG:G | acceptor_gain | 1.0000 |
| 5:149348271:GGG:G | acceptor_gain | 1.0000 |
| 5:149348271:GGGG:G | acceptor_gain | 1.0000 |
| 5:149348271:GGGGA:G | acceptor_gain | 1.0000 |
| 5:149348423:ACA:A | donor_gain | 1.0000 |
| 5:149348424:CA:C | donor_gain | 1.0000 |
| 5:149348424:CAGT:C | donor_loss | 1.0000 |
| 5:149348425:AGT:A | donor_loss | 1.0000 |
| 5:149348426:G:GG | donor_gain | 1.0000 |
| 5:149349644:T:TA | acceptor_gain | 1.0000 |
| 5:149349650:TCA:T | acceptor_loss | 1.0000 |
| 5:149349651:CA:C | acceptor_loss | 1.0000 |
| 5:149349652:AGG:A | acceptor_loss | 1.0000 |
| 5:149349734:TGG:T | donor_loss | 1.0000 |
| 5:149349736:G:A | donor_loss | 1.0000 |
| 5:149349736:G:GG | donor_gain | 1.0000 |
| 5:149349737:T:G | donor_loss | 1.0000 |
| 5:149345614:C:T | donor_gain | 0.9900 |
| 5:149345616:AGTAA:A | donor_loss | 0.9900 |
| 5:149345617:G:GA | donor_loss | 0.9900 |
AlphaMissense
1442 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:149349732:T:C | F104L | 0.995 |
| 5:149349734:T:A | F104L | 0.995 |
| 5:149349734:T:G | F104L | 0.995 |
| 5:149349723:G:C | A101P | 0.993 |
| 5:149351209:G:A | G202D | 0.992 |
| 5:149350932:T:C | C110R | 0.991 |
| 5:149349669:G:C | A83P | 0.990 |
| 5:149350933:G:A | C110Y | 0.990 |
| 5:149350934:T:G | C110W | 0.990 |
| 5:149351211:T:G | Y203D | 0.990 |
| 5:149351233:T:A | I210N | 0.990 |
| 5:149351065:T:C | L154P | 0.989 |
| 5:149350953:G:C | A117P | 0.987 |
| 5:149351226:C:A | R208S | 0.987 |
| 5:149351227:G:C | R208P | 0.987 |
| 5:149351236:G:T | R211M | 0.987 |
| 5:149350918:G:A | G105E | 0.985 |
| 5:149351218:T:C | L205P | 0.984 |
| 5:149349700:G:C | R93P | 0.983 |
| 5:149351188:T:A | V195E | 0.983 |
| 5:149350930:T:C | F109S | 0.982 |
| 5:149351212:A:C | Y203S | 0.982 |
| 5:149351233:T:G | I210S | 0.982 |
| 5:149351092:T:C | L163P | 0.981 |
| 5:149351233:T:C | I210T | 0.981 |
| 5:149351236:G:C | R211T | 0.981 |
| 5:149351242:C:A | A213D | 0.981 |
| 5:149351237:G:C | R211S | 0.980 |
| 5:149351237:G:T | R211S | 0.980 |
| 5:149351208:G:C | G202R | 0.977 |
dbSNP variants (sampled 300 via entrez): RS1000202482 (5:149350155 T>A,C), RS1000280045 (5:149346326 T>C), RS1000291378 (5:149346555 T>C), RS1001071984 (5:149345353 C>G), RS1001248314 (5:149352233 AT>A,ATT,ATTT), RS1001558648 (5:149349051 A>G), RS1001753970 (5:149346860 C>T), RS1001984265 (5:149350481 T>C), RS1002036980 (5:149343863 C>T), RS1002050635 (5:149348704 C>T), RS1002105758 (5:149344330 G>A), RS1002354570 (5:149350230 G>T), RS1002965234 (5:149347682 T>A), RS1003375569 (5:149348169 C>A,G,T), RS1003429528 (5:149348441 A>G)
Disease associations
OMIM: gene MIM:618545 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
39 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression | 3 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Leflunomide | increases expression | 2 |
| Tetrachlorodibenzodioxin | decreases expression | 2 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| bufotalin | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| chloropicrin | affects expression | 1 |
| K 7174 | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Atrazine | decreases expression | 1 |
| Cisplatin | increases expression | 1 |
| Diethylhexyl Phthalate | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Estradiol | increases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Phenobarbital | affects expression | 1 |
| Plant Oils | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Urethane | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.